Increased interleukin-22 levels in lupus nephritis and its associated with disease severity: a study in both patients and lupus-like mice model.

CONCLUSIONS: Our results suggest that IL-22 as a pathogenic cytokine might be a potential target for treatment of lupus nephritis.
PMID: 30299250 [PubMed - as supplied by publisher]

Source: Clinical and Experimental Rheumatology - October 10, 2018 Category: Rheumatology Tags: Clin Exp Rheumatol Source Type: research